Download eBook for Free
| Format | File Size | Notes |
|---|---|---|
| PDF file | 2 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Psychiatrists, nurse practitioners, and other prescribing clinicians who work in mental health settings are in an optimal position to treat an alcohol use disorder (AUD) that co-occurs with a primary mental health condition experienced by clients in these settings. U.S. Food and Drug Administration–approved medications are available and appropriate for use in mental health settings to enhance the effectiveness of mental health treatment. This tool provides a "how-to" guide to identifying and treating clients with a co-occurring alcohol use disorder in mental health settings. It also includes a prescriber summary that defines a strategy for prescribing AUD medications in mental health settings.
This guide is divided into three parts. In Part I, the authors include information about identifying and diagnosing an AUD. In Part II, they review administering naltrexone long-acting injection, and in Part III, they review oral medications for AUD.
Table of Contents
Part I
Medications for Alcohol Use Disorder in Mental Health Settings
Section One
Evaluating Clients for Co-AUD
Section Two
Prescribing Medications to Clients with Co-AUD
Part II
Administering Naltrexone Long-Acting Injection to Clients with Co-AUD: A Step-By-Step Guide for Mental Health Clinicians and Providers
Section One
Quick Guide for Administering Naltrexone Long-Acting Injection
Section Two
Determining Client Appropriateness for Treatment with Naltrexone Long-Acting Injection: Visit 1
Section Three
Administering Naltrexone Long-Acting Injection
Section Four
Assessing Treatment Progress and Adverse Events and Administering Additional Medication Doses, If Appropriate
Part III
Prescribing Oral Medications for Clients with Co-AUD
Appendix A
Pre-Injection Checklist for Appropriateness for Naltrexone Long-Acting Injection
Appendix B
Risks of Naltrexone Long-Acting Injection Worksheet (English and Spanish Versions)
Appendix C
Step-by-Step Instructions for the Preparation and Injection of Naltrexone Long-Acting Injection
Appendix D
Follow-Up Visit Pre-Injection Checklists
Appendix E
DSM-5 AUD Diagnosis Worksheet
Appendix F
CIWA-Ar Worksheet
Appendix G
Wallet Cards
Research conducted by
This research was funded by the National Institute on Alcohol Abuse and Alcoholism and conducted by the Access and Delivery Program within RAND Health Care.
This report is part of the RAND Corporation Tool series. RAND tools may include models, databases, calculators, computer code, GIS mapping tools, practitioner guidelines, web applications, and various toolkits. All RAND tools undergo rigorous peer review to ensure both high data standards and appropriate methodology in keeping with RAND's commitment to quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.